Prostate

Another great interview from Dr. Bernie! * debunk the long-standing myth that testosterone fuels prostate cancer In this episode, Dr. Geo interviews Dr. Helen Bernie from Indiana University about Testosterone Replacement Therapy (TRT)...

ABSTRACT Men with hypogonadism have reduced risk of prostate cancer mortality; whether testosterone treatment increases the risk of prostate safety events in men with hypogonadism remains controversial. Several studies including four larger...

What factors can falsely elevate your PSA level? There are other factors that can affect the PSA level besides prostate cancer. The following conditions can lead to increased PSA levels: Increasing age Benign prostate hyperplasia (BPH), a...

“The 2018 AUA guidelines for testosterone therapy that were co-chaired by Dr. John P. Mulhall say that we have an absence or a paucity of data on using testosterone therapy on active surveillance,” says Helen L. Bernie, DO, MPH...

https://grandroundsinurology.com/making-sense-of-bph-which-treatment-for-which-patient-review-of-guidelines-for-bph/ Seth K. Bechis, MD, reviews the 2023 American Urological Association (AUA) guidelines for benign prostatic hyperplasia (BPH)...

https://www.issm.info/meetings/issm-uncovered-podcast/issm-podcast-season-1-episode-35 Join us in this episode, with guest Giorgio Russo and host Shelly Varod, as we delve into the world of nutraceuticals, those intriguing compounds bridging the...

0:15 What could cause blood to appear in someone's urine? 2:51 Can BPH ever cause blood to appear in the urine? 4:50 What is the procedure of getting a cystoscopy like? 5:47 How easily accessible is Cxbladder? Its out covered by insurance...

https://www.urotoday.com/conference-highlights/aua-2024/aua-2024-prostate-cancer/151946-aua-2024-crossfire-controversies-in-urology-testosterone-therapy-may-be-reasonably-offered-to-men-on-active-surveillance-pro-con.html (UroToday.com) Recent...

In this episode we discuss Optilume, a novel treatment for the urinary symptoms experienced by men due to an enlarged or obstructing prostate (BPH). In previous episodes, we have covered a variety of other BPH treatments ranging from the...

0:22 What is the difference between a "genetic" and a "genomic" test? 1:12 How important is genetic or genomic testing to the average prostate cancer patient? 3:31 Do 5% of people have a BRCA mutation? 3:42 Should all prostate cancer...

"We've been doing a lot of work at Johns Hopkins using high-dose testosterone therapies to treat patients with metastatic prostate cancer," says Mark C. Markowski, MD, PhD...

In this video, Dr. Aday discusses the latest advancements in active surveillance for prostate cancer. He explains the history of prostate cancer diagnosis and the limitations of the PSA test. He outlines the criteria for eligibility for active...